-
Janssen Lost Little Ground on Trials Due To COVID-19
Clinical Research News | Many of the process-related changes Janssen made in response to COVID-19—including virtual investigator meetings, analytic risk-based monitoring (ARBM), and direct-to-participant clinical trial approaches—will endure beyond the pandemic.
Mar 10, 2021
-
Solving Real Problems from the Depths of the Technology Echo Chamber
Clinical Research News | Much is said about how technology can transform healthcare with countless technologies being explored and used like machine learning, IoT, wearables, biosensors, natural-language processing, and digital therapeutics. But before we chase the latest and greatest technology, we must ask the critical question: “What problem are we trying to solve?”
Mar 9, 2021
-
How Pfizer’s ‘Science Will Win’ Mantra Played Out Behind The Scenes
Clinical Research News | One year after COVID-19 was declared a pandemic by the World Health Organization, a handful of Pfizer clinical operations leaders talked openly about the “one-team mindset” that helped usher a safe and highly efficacious vaccine to market in record time.
Mar 8, 2021
-
Data-as-a-Service for Trials, Real World Data, Genomics Data For Cancer Trials: News and Products for February
Clinical Research News | Wearables for blood cancer clinical trials, new members of DTRA, new light and health research center, digital twin consortium, and more.
Mar 8, 2021
-
Oral Disorders Linked to SARS-CoV-2, Statin Use Increases Survival Rate, Abnormal Sodium Levels Predict Death Risk: COVID-19 Updates
Clinical Research News I Repurposed arthritis drug falls short in Phase 3 clinical trial, optimal timing for donating convalescent plasma is within 60 days of symptom onset, most pregnant women and mothers report that they will vaccinate themselves and children, and only small percentage of COVID-19 patients suffer stroke, risk increases with age and CV risk factors. Plus: Clinicians warn of delayed injection-site reaction to Moderna vaccine for proper management and swollen salivary glands may be a common COVID-19 side effect.
Mar 5, 2021
-
SCOPE 2021: New Players in Clinical Trials, AstraZeneca on RWE, Transcelerate Updates
Clinical Research News | Day two of the Summit for Clinical Ops Executives (SCOPE) brings more updates from big pharma on the impacts of the COVID-19 pandemic, how AstraZeneca in deploying real-world evidence (RWE) in trials across broad therapeutic areas, and more.
Mar 4, 2021
-
Medidata Named Winner of 2021 Participant Engagement Award
Clinical Research News | Live at SCOPE yesterday, the winner of the 2021 Participant Engagement Award was chosen by a panel of judges. Patient Centricity by Design, a project from Medidata, was named the grand prize winner.
Mar 3, 2021
-
SCOPE 2021: Pfizer, GSK’s Approach to COVID-19 Research, Patient Voice In Trials
Clinical Research News | At the kickoff day for the Summit for Clinical Ops Executives 2021, teams from Pfizer talk vaccine development, Bayer, Pfizer, Abbvie and GSK report on the role of the patient in trial development, and GSK discusses the need for a “single source of truth” in pandemic response.
Mar 3, 2021
-
Pandemic Highlights Value Of Remote Clinical Trials, Drug Repurposing
Clinical Research News | A keynote address earlier this morning during opening ceremonies of the 2021 Summit for Clinical Ops Executives (SCOPE) offers glimmers of hope that the notoriously rigid clinical trial process may retain at least a few of the warp-speed changes introduced by the COVID-19 pandemic.
Mar 2, 2021
